EVALUACIÓN IN VITRO DEL PERFIL DE CITOCINAS Y FENOTIPO INDUCIDO POR ESPECIES DE Streptococcus ORALES EN CÉLULAS DENDRÍTICAS CONDICIONADAS POR QUERATINOCITOS GINGIVALES

A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma

Cardona, AF; (...); Arrieta, O

Article. 10.1007/s12094-019-02066-2. 2019

• 
• 
• 7

  

Antibiotics impair immune checkpoint inhibitor effectiveness in Hispanic patients with non-small cell lung cancer (AB-CLICaP)

Ruiz-Patiño A.; (...); Arrieta O.

Article. 10.1111/1759-7714.13573. 2020

• 
• 
• 13

  

Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non-small cell lung cancer

Arrieta O; (...); Ramirez-Tirado L.-A.

Article. 10.1002/cam4.2882. 2020

• 
• 
• 52

  

Atypical Skin Manifestations During Immune Checkpoint Blockage in Coronavirus Disease 2019–Infected Patients With Lung Cancer

Rolfo C; (...); Arrieta O

Article. 10.1016/j.jtho.2020.06.019. 2020

• 
• 
• 10

  

Brigatinib inALK-positive non-small cell lung cancer: real-world data in the Latin American population (Bri-world extend CLICaP)

Heredia, D; (...); Arrieta, O

Article. 10.2217/fon-2020-0747. 2020

• 8

  

Corrigendum to “Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)” [Crit. Rev. Oncol. Hematol. 151 (July) (2020) 102978] (Critical Reviews in Oncology / Hematology (2020) 151, (S1040842820301165), (10.1016/j.critrevonc.2020.102978))

Rolfo C.; (...); Serrano M.J.

Correction. 10.1016/j.critrevonc.2020.103058. 2020

• 
• 8

  

Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB)

Rolfo C.; (...); Serrano M.J.

Review. 10.1016/j.critrevonc.2020.102978. 2020

• 
• 98

  

Characterization of Hispanic Patients Who Experienced Hyperprogression During Treatment for Advanced NSCLC with Immunotherapy

Arrieta, OG; (...); Rosell, R

Meeting Abstract. 10.1016/j.jtho.2019.08.984. 2019

• 
• 2

  

Chronic and Severe Non-Lichenoid Oral Ulcers Induced by Nivolumab - Diagnostic and Therapeutic Challenge: A Case Report

Cardona AF; (...); Arrieta O

Article. 10.1159/000505968. 2020

• 
• 
• 7

  

Chronic and Severe Non-Lichenoid Oral Ulcers Induced by Nivolumab: Diagnostic and Therapeutic Challenge

Cardona, AF; (...); Arrieta, OG

Meeting Abstract. 10.1016/j.jtho.2019.08.2164. 2019

• 
• 1

  

Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma A Phase 2 Randomized Clinical Trial

Arrieta, O; (...); Rosell, R

Article. 10.1001/jamaoncol.2019.2553. 2019

• 
• 
• 147

  

Efficacy and Safety of Pembrolizumab Plus Docetaxel vs Docetaxel Alone in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer: The PROLUNG Phase 2 Randomized Clinical Trial

Arrieta O; (...); Rosell R

Article. 10.1001/jamaoncol.2020.0409. 2020

• 
• 
• 131

  

EGFR exon 20 insertions in advanced non-small cell lung cancer: A new history begins

Remon J; (...); Besse B

Review. 10.1016/j.ctrv.2020.102105. 2020

• 
• 
• 105

  

EGFR Inhibitors Plus Bevacizumab Are Superior Compared to EGFR Inhibitor Monotherapy in Advanced EGFR plus NSCLC Patients with BIM Deletions

Cardona, AF; (...); Rosell, R

Meeting Abstract. 10.1016/j.jtho.2019.08.1212. 2019

• 
• 1

  

Electronic nicotine delivery systems (ECs) and COVID-19: the perfect storm for young consumers

Pino, LE; (...); Cardona, AF

Review. 10.1007/s12094-020-02391-x. 2021

• 
• 
• 10

  

Exploration of Factors Relating to Paradoxical Immune Response in Patients Treated with Immune Checkpoint Inhibitors for NSCLC

Cardona, AF; (...); Rosell, R

Meeting Abstract. 10.1016/j.jtho.2019.08.2129. 2019

Immunotherapy at Any Line Improves Survival in Hispanic Patients with Advanced Metastatic NSCLC Compared to Chemotherapy (Quijote-CLICaP)

Cardona, AF; (...); Rosell, R

Meeting Abstract. 10.1016/j.jtho.2019.08.2163. 2019

• 
• 4

  

Immunotherapy at any line of treatment improves survival in patients with advanced metastatic non-small cell lung cancer (NSCLC) compared with chemotherapy (Quijote-CLICaP)

Ruiz-Patiño A.; (...); Rosell R.

Article. 10.1111/1759-7714.13272. 2020

• 
• 
• 50

  

Immunotherapy-Related Thrombosis: Considerations and Associated Factors in Non-Small Cell Lung Cancer (NSCLC) Patients

Cardona, AF; (...); Rosell, R

Meeting Abstract. 10.1016/j.jtho.2019.08.983. 2019

Lung Cancer Disparities in Hispanics: Molecular Diagnosis and Use of Immunotherapy

Raez LE; (...); Lopes G

Note. 10.1200/GO.20.00004. 2020

• 
• 
• 23

  

Mortality and advanced support requirement for patients with cancer with COVID-19: A mathematical dynamic model for latin America

Ruiz-Patiño A; (...); Cardona AF

Article. 10.1200/GO.20.00156. 2020

• 
• 
• 14

  

Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP)

Cardona, AF; (...); Arrieta, O

Article. 10.3389/fonc.2019.00254. 2019

• 
• 
• 28

  

Overcoming TKI resistance in fusion-driven NSCLC: New generation inhibitors and rationale for combination strategies

Russo A; (...); Rolfo C

Review. 10.21037/tlcr-2019-cnsclc-06. 2020

• 
• 
• 15

  

Precision medicine and its implementation in patients with NTRK fusion genes: perspective from developing countries

Cardona, AF; (...); Rosell, R

Review. 10.1177/1753466620938553. 2020

• 
• 
• 12

  

Precision prevention and cancer interception: The new challenges of liquid biopsy

Serrano M.J.; (...); Rolfo C.

Article. 10.1158/2159-8290.CD-20-0466. 2020

• 
• 76

  

Real World Characterization and Treatment of Patients with Thymic Carcinoma: Lessons from a Latin-American Study (CLICaP-LATimus)

Mas, L; (...); Remon, J

Meeting Abstract. 2019

Relevance of Antibiotic Use on Clinical Activity of Immune Checkpoint Inhibitors in Hispanic Patients with Advanced NSCLC (CLICAP-ABs)

Barrón, F; (...); Rosell, R

Meeting Abstract. 10.1016/j.jtho.2019.08.2131. 2019

• 
• 2

  

Scientific Productivity and Cancer-Related Mortality: A Case Study of a Positive Association in Colombia

Bravo-Linares, D; (...); Cardona, AF

Article. 10.1200/JGO.19.00164. 2019

• 
• 
• 4

  

Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study)

Ruiz-Patiño A; (...); Rosell R

Article. 10.1016/j.jclinepi.2020.05.033. 2020

• 
• 9

  

Squamous cell lung cancer: genomic evolution and personalized therapy

Cardona, AF; (...); Arrieta, O

Review. 10.21149/10115. 2019

• 
• 
• 9

  

Survival of Thymoma Is Extensive in Latin-American Patients: Results from Over 10 Years of Experience (CLICaP-LATimus)

Mas, L; (...); Remon, J

Meeting Abstract. 2019

Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib

Cardona, AF; (...); Arrieta, O

Article. 10.1371/journal.pone.0217340. 2019

• 
• 
• 25

  

The Role of a Cachexia Grading System in Patients with Non-Small Cell Lung Cancer Treated with Immunotherapy: Implications for Survival

Turcott, JG; (...); Arrieta, O

Article. 10.1080/01635581.2020.1769691. 2021

• 
• 12

  

Evaluación Del Efecto Citotóxico Y Sobre El Ciclo Celular De Extractos De Lycium Barbarum Y Lycopersicum Esculentum En Queratinocitos Orales Tumorales

Trabajo de grado de pregrado

Director/es: LAFAURIE, GLORIA INES; PERDOMO, SANDRA JANNETH; CARDONA, ANDRES FELIPE

Evaluación In Vitro Del Efecto De Pueraria Lobata Y Schisandra Chinensis En Queratinocitos Tumorales Transformados Por Vph-18

Trabajo de grado de pregrado

Director/es: LAFAURIE, GLORIA INES; PERDOMO, SANDRA JANNETH; CARDONA, ANDRES FELIPE